atopica for cats- cyclosporine solution
elanco us inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 100 mg in 1 ml - do not use in cats with a history of malignant disorders or suspected malignancy. do not use in cats infected with feline leukemia virus (felv) or feline immunodeficiency virus (fiv). do not use in cats with a hypersensitivity to cyclosporine. instructions for assembling the dispensing system and preparing a dose of atopica ™ for cats (cyclosporine oral solution) usp modified assembling the dispensing system the dispensing system consists of 4 parts: - a bottle containing the medicine, with rubber stopper and a screw cap to close the bottle after use. - a plastic adapter with dip tube that you will push into the neck of the bottle. the adapter must always remain in the bottle after first use. - an oral dosing syringe that fits into the top of the plastic adapter to withdraw the prescribed dose of medicine from the bottle. - a plastic vial containing the plastic adapter and oral dosing syringe. save the plastic vial to store the oral dosing syringe between each use. fitting the plastic adapter into the new b
atopica- cyclosporine capsule, gelatin coated
elanco us inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 10 mg - atopica is indicated for the control of atopic dermatitis in dogs weighing at least 4 lbs. (1.8 kg) body weight. atopica is contraindicated for use in dogs with a history of neoplasia. do not use in dogs with a hypersensitivity to cyclosporine.
pms-cyclosporine capsule
pharmascience inc - cyclosporine - capsule - 25mg - cyclosporine 25mg - immunosuppressive agents
pms-cyclosporine capsule
pharmascience inc - cyclosporine - capsule - 100mg - cyclosporine 100mg - immunosuppressive agents
pms-cyclosporine capsule
pharmascience inc - cyclosporine - capsule - 50mg - cyclosporine 50mg - immunosuppressive agents
cycloserine 250mg capsules
p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - cycloserine - hard capsule - cycloserine 250 mg - antimycobacterials
cyclosporine emulsion
a-s medication solutions - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine ophthalmic emulsion, 0.05% is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. cyclosporine ophthalmic emulsion is contraindicated in patients with known or suspected hypersensitivity to any of the ingredients in the formulation. risk summary clinical administration of cyclosporine ophthalmic emulsion 0.05% is not detected systemically following topical ocular administration [see clinical pharmacology ( 12.3 ) ], and maternal use is not expected to result in fetal exposure to the drug. oral administration of cyclosporine to pregnant rats or rabbits did not produce teratogenicity at clinically relevant doses [see data ]. data animal data at maternally toxic doses (30 mg/kg/day in rats and 100 mg/kg/day in rabbits), cyclosporine oral solution (usp) was te
cyclosporine capsule
sandoz canada incorporated - cyclosporine - capsule - 25mg - cyclosporine 25mg - immunosuppressive agents
cycloserine 250mg capsules
neon healthcare ltd - cycloserine - oral capsule - 250mg
cyclosporin sandoz
sandoz pty ltd - cyclosporin -